Novavax Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones

Dec 03, 2024

DJ Novavax Inc. Stock Rises Monday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. $(NVAX)$ inched 0.57% higher to $8.77 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.97% to 19,403.95 and the Dow Jones Industrial Average falling 0.29% to 44,782.00.

This was the stock's second consecutive day of gains.

Novavax Inc. closed $15.09 short of its 52-week high ($23.86), which the company achieved on June 6th.

The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.14% to $154.80, Pfizer Inc. $(PFE)$ fell 1.49% to $25.82, and Merck & Co. Inc. $(MRK)$ fell 1.01% to $100.61.

Trading volume (3.0 M) remained 3.3 million below its 50-day average volume of 6.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 02, 2024 17:29 ET (22:29 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2488698490"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2488698490\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2488698490?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-03 06:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2488698490","market":"other","top_or_hot":-1,"title":"Novavax Inc. Stock Rises Monday, Still Underperforms Market","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Novavax Inc. Stock Rises Monday, Still Underperforms Market\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> inched 0.57% higher to $8.77 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.97% to 19,403.95 and the Dow Jones Industrial Average  falling 0.29% to 44,782.00. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Novavax Inc. closed $15.09 short of its 52-week high ($23.86), which the company achieved on June 6th. \n</p>\n<p>\n     The stock outperformed some of its competitors Monday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.14% to $154.80, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 1.49% to $25.82, and Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> fell 1.01% to $100.61. \n</p>\n<p>\n     Trading volume (3.0 M) remained 3.3 million below its 50-day average volume of 6.3 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 02, 2024 17:29 ET (22:29 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Inc. Stock Rises Monday, Still Underperforms Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Inc. Stock Rises Monday, Still Underperforms Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-12-03 06:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Novavax Inc. Stock Rises Monday, Still Underperforms Market\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Novavax Inc. <a href=\"https://laohu8.com/S/NVAX\">$(NVAX)$</a> inched 0.57% higher to $8.77 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.97% to 19,403.95 and the Dow Jones Industrial Average  falling 0.29% to 44,782.00. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Novavax Inc. closed $15.09 short of its 52-week high ($23.86), which the company achieved on June 6th. \n</p>\n<p>\n     The stock outperformed some of its competitors Monday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 0.14% to $154.80, Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> fell 1.49% to $25.82, and Merck &amp; Co. Inc. <a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> fell 1.01% to $100.61. \n</p>\n<p>\n     Trading volume (3.0 M) remained 3.3 million below its 50-day average volume of 6.3 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 02, 2024 17:29 ET (22:29 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVAX","symbol_name":"诺瓦瓦克斯医药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2488698490","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488698490","pubTimestamp":1733178540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  inched 0.57% higher to $8.77 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.97% to 19,403.95 and the Dow Jones Industrial Average  falling 0.29% to 44,782.00.This was the stock's second consecutive day of gains.Novavax Inc. closed $15.09 short of its 52-week high , which the company achieved on June 6th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 0.14% to $154.80, Pfizer Inc.  fell 1.49% to $25.82, and Merck & Co. Inc.  fell 1.01% to $100.61.Trading volume  remained 3.3 million below its 50-day average volume of 6.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Stre","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"translate_title":"Novavax Inc.股价周一上涨，但仍跑输大盘","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVAX":1},"content_text":"DJ Novavax Inc. Stock Rises Monday, Still Underperforms Market\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Novavax Inc. $(NVAX)$ inched 0.57% higher to $8.77 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.97% to 19,403.95 and the Dow Jones Industrial Average  falling 0.29% to 44,782.00. \n\n\n     This was the stock's second consecutive day of gains. \n\n\n     Novavax Inc. closed $15.09 short of its 52-week high ($23.86), which the company achieved on June 6th. \n\n\n     The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.14% to $154.80, Pfizer Inc. $(PFE)$ fell 1.49% to $25.82, and Merck & Co. Inc. $(MRK)$ fell 1.01% to $100.61. \n\n\n     Trading volume (3.0 M) remained 3.3 million below its 50-day average volume of 6.3 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2024 17:29 ET (22:29 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}